2 Stocks Ttrending High Today – PCK, IP1 

2 Stocks Ttrending High Today - PCK, IP1 

PainChek Limited

PainChek Limited (ASX: PCK) aspires to lead the market in the innovative pain assessment products by offering services to help improve the quality of life for people suffering from pain. The company’s pain assessment mobile device PainChek® has received regulatory clearance from both Australia and Europe.

On 30 April 2019, the company provided the quarterly update for the period from January to March 2019. PCK mentioned that PainChek® had experienced another positive sales quarter. It is swiftly turning the new standard for pain assessment within Australian Residential Aged Care (RAC). The number of PainChek® clinical assessments have risen from 18,030 to more than 23,000 confirming strong take-up and clinical utility of the App. The company is expecting $5 million investment from Morrison Government for app’s penetration in Australia’s RACs.

From the cash flow perspective on 31 March 2019, the company reported that A$686k net cash was used in operating activities standing. The net cash inflow from financing activities stood at A$350k. The cash and cash equivalents at the end of the quarter was recorded at A$1,992k.

The stock of the company closed the day’s trading at A$0.068, up by a massive 100% (as on 30 April 2019). The company has a market capitalisation of A$29.07 million with approximately 855.13 million shares outstanding. In the last six months period, the stock has generated a negative return of 27.66%. However, over the last month, the stock has given a yield of 13.33%.

Integrated Payment Technologies Limited

Integrated Payment Technologies Limited (ASX: IP1) is a Sydney based company which offers integrated electronic payment remittance solutions in the Australian region. It provides ClickSuper Service, Payment Advisor Service and Bill Exchange Service. It was founded in 2006, and Mr Don Sharp is the Executive Chairman of the company.

On 26 April 2019, the company notified the market about the change of interests of one of its directors Mr Robin Beauchamp who had acquired 2,070,645 ordinary shares on 18 April 2019 at a value of $0.01 per share and thereby holding a total of $4.14 million ordinary shares. The acquisition of newly issued shares by take-up of entitlements was under the institutional component of the Company’s accelerated non-renounceable entitlement offer.

On 23 April 2019, the company announced the change of interests of its substantial holder Colin Scully, Valebark Pty Ltd and Starmay Superannuation Pty Ltd effective 18 April 2019. Before the notice, Colin Scully and Valebark Pty Ltd had 49,843,145 ordinary shares with the voting power of 32.28%. The present notice reflects 99,686,290 ordinary shares with the voting power of 43.1%. Also, Starmay Superannuation Pty Ltd earlier held 23,242,303 ordinary shares with the voting power of 15.05%. The present notice reflects 46,484,606 ordinary shares with the voting power of 20.1%.

In its quarterly report, for the period ending on 31 March 2019, the company mentioned the net cash used in operating activities at A$265k. The net cash used in investing activities was A$275k. The cash and cash equivalents at the end of the quarter was recorded at A$546k. The total estimated cash outflows for the next quarter is A$859k.

The stock of the company closed the day’s trading at A$0.015, up by 7.143% (as on 30 April 2019,). The company has a market capitalisation of A$3.24 million with circa 231.49 million shares outstanding. The stock has generated a negative return of 57% in the last twelve months.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report